Search

Your search keyword '"Hillemanns, Peter"' showing total 291 results

Search Constraints

Start Over You searched for: Author "Hillemanns, Peter" Remove constraint Author: "Hillemanns, Peter" Publication Type Electronic Resources Remove constraint Publication Type: Electronic Resources
291 results on '"Hillemanns, Peter"'

Search Results

1. Criteria for second generation comparator tests in validation of novel HPV DNA tests for use in cervical cancer screening

2. Criteria for second generation comparator tests in validation of novel HPV DNA tests for use in cervical cancer screening

3. CLDN6-specific CAR-T cells plus amplifying RNA vaccine in relapsed or refractory solid tumors:the phase 1 BNT211-01 trial

4. Spectrum and Frequency of Germline FANCM Protein-Truncating Variants in 44,803 European Female Breast Cancer Cases

5. FANCM missense variants and breast cancer risk:a case-control association study of 75,156 European women

6. Spectrum and Frequency of Germline FANCM Protein-Truncating Variants in 44,803 European Female Breast Cancer Cases

7. Physical activity, sedentary time and breast cancer risk : a Mendelian randomisation study

8. Physical activity, sedentary time and breast cancer risk: a Mendelian randomisation study.

9. Physical activity, sedentary time and breast cancer risk: a Mendelian randomisation study

10. Diagnosis, Therapy and Follow-up of Cervical Cancer Guideline of the DGGG, DKG and DKH (S3-Level, AWMF Registry No. 032/033OL, May 2021) - Part 1 with Recommendations on Epidemiology, Screening, Diagnostics and Therapy

11. Diagnosis, Therapy and Follow-up of Cervical Cancer Guideline of the DGGG, DKG and DKH (S3-Level, AWMF Registry No. 032/033OL, May 2021) - Part 2 with Recommendations on Psycho-oncology, Rehabilitation, Follow-up, Recurrence, Palliative Therapy and Healthcare Facilities

12. Physical activity, sedentary time and breast cancer risk:a Mendelian randomisation study

13. Physical activity, sedentary time and breast cancer risk:a Mendelian randomisation study

14. Pleiotropy-guided transcriptome imputation from normal and tumor tissues identifies candidate susceptibility genes for breast and ovarian cancer.

15. CRBP-TS - evaluation of a home-based training and health care program for colorectal, breast, and prostate cancer using telemonitoring and self-management: study protocol for a randomized controlled trial

16. Mendelian randomization analyses suggest a role for cholesterol in the development of endometrial cancer

17. CRBP-TS - evaluation of a home-based training and health care program for colorectal, breast, and prostate cancer using telemonitoring and self-management: study protocol for a randomized controlled trial

18. German evidence and consensus-based (S3) guideline: Vaccination recommendations for the prevention of HPV-associated lesions

19. Pleiotropy-guided transcriptome imputation from normal and tumor tissues identifies candidate susceptibility genes for breast and ovarian cancer.

20. Breast Cancer Risk Genes - Association Analysis in More than 113,000 Women.

21. CRBP-TS - evaluation of a home-based training and health care program for colorectal, breast, and prostate cancer using telemonitoring and self-management: study protocol for a randomized controlled trial

22. Cross-Cancer Genome-Wide Association Study of Endometrial Cancer and Epithelial Ovarian Cancer Identifies Genetic Risk Regions Associated with Risk of Both Cancers

23. German evidence and consensus-based (S3) guideline: Vaccination recommendations for the prevention of HPV-associated lesions

24. Pleiotropy-guided transcriptome imputation from normal and tumor tissues identifies candidate susceptibility genes for breast and ovarian cancer

25. CRBP-TS - evaluation of a home-based training and health care program for colorectal, breast, and prostate cancer using telemonitoring and self-management: study protocol for a randomized controlled trial

26. Pleiotropy-guided transcriptome imputation from normal and tumor tissues identifies candidate susceptibility genes for breast and ovarian cancer

27. Cross-cancer genome-wide association study of endometrial cancer and epithelial ovarian cancer identifies genetic risk regions associated with risk of both cancers.

28. Randomized Trial of Cytoreductive Surgery for Relapsed Ovarian Cancer

29. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses

30. Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk

31. Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk

32. Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk

33. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses.

34. Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk.

35. Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes

36. Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk

37. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses

38. Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk.

39. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses.

40. Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk

41. Cross-cancer genome-wide association study of endometrial cancer and epithelial ovarian cancer identifies genetic risk regions associated with risk of both cancers

42. Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes

43. Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk

44. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses

45. Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk

46. Characterization of a Novel Third-Generation Anti-CD24-CAR against Ovarian Cancer

47. Associations of obesity and circulating insulin and glucose with breast cancer risk : a Mendelian randomization analysis

48. Genome-wide association study of germline variants and breast cancer-specific mortality

49. Shared heritability and functional enrichment across six solid cancers

50. Two truncating variants in FANCC and breast cancer risk

Catalog

Books, media, physical & digital resources